GLP-1

Wegovy
Health Tech

Hims & Hers stock drops 30% after Novo Nordisk terminates deal

Hims & Hers stock plunged 30% on Monday after Novo Nordisk abruptly ended a collaboration to offer direct access to its weight loss drug Wegovy.
Heather Landi Jun 23, 2025 12:00pm
Anti-obesity medication in a tiny shopping cart

DoseSpot study: Many patients are overpaying for GLP-1s

Jun 23, 2025 6:00am
Human hands connecting puzzles

Cost Plus Drugs partners with 9amHealth on obesity care drugs

Jun 18, 2025 6:00am
Two packages of a fictitious Semaglutide drug used for weight loss

Lark Health unveils AI-powered tool to manage GLP-1 costs

Jun 17, 2025 6:00am
Two executives shaking hands on blue background

PBM Capital Rx absorbs care navigation company Amino Health

Jun 11, 2025 6:50am
Drug Prices

PSG report: Employers weigh 'unbundling' PBM models, GLP-1s

Jun 10, 2025 9:30am